BSX vs EGAN · P/E 20, rev $16.75B vs P/E 68, rev $88.4M
Boston Scientific Corp (BSX) versus eGain Corporation (EGAN) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
eGain Corporation (EGAN) is a software - application company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported EGAN revenue for 2025-06-30 was $88.4M. Net income was $32.3M. Revenue was up 293.7% from 2024-06-30 to 2025-06-30. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
Not investment advice. Open the BSX and EGAN stock pages for the full models.
Not investment advice.